Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: A possible approach to the immunotherapy of human tumors

Michael T. Lotze, Kevan Roberts, Mary C. Custer, David A. Segal, Steven A. Rosenberg

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: A possible approach to the immunotherapy of human tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences